SynthesisFrontiers in oncology2023

Comparison of doublet and triplet therapies for metastatic hormone-sensitive prostate cancer: A systematic review and network meta-analysis.

Lei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.